- Advanced Flower Capital announced its intention to convert from a REIT to a business development company (BDC), subject to shareholder approval.
- The conversion aims to enable AFC to invest in a broader range of assets, including non-real estate opportunities, addressing industry limitations.
- Management believes the BDC structure will better position AFC to capitalize on sector tailwinds, especially if cannabis rescheduling occurs.
- The expanded investment mandate will include direct lending outside cannabis, diversifying the company's risk profile.
- The conversion is expected to occur in the first quarter of 2026, pending regulatory and shareholder approvals.
- This strategic shift is driven by the high cost of capital and the limited real estate ownership among cannabis operators.
Explore Similar Insights
- Orion is actively shifting its portfolio focus from traditional suburban office properties to dedicated use assets such as medical, lab, R&D flex, and non-CBD government properties.
- As of quarter end, approximately 32.2% of the portfolio by annualized base rent and 25.3% by square footage are DUA properties, with plans to increase these percentages over time.
- Management believes DUA assets exhibit stronger renewal trends, higher tenant investment, and more durable cash flows, supporting their strategic pivot.
- The company is exploring targeted acquisitions in the DUA segment to accelerate this transition and enhance portfolio quality.
- This strategic repositioning aims to reduce exposure to traditional office risks and capitalize on more resilient property types.
- RMR has focused on deleveraging through asset sales and refinancings.
- Share prices of DHC and ILPT increased substantially year-to-date.
- Share price improvements led to potential incentive fees exceeding $17 million for RMR.
- Active asset management and sector fundamentals contributed to strong performance.
- Management emphasized the importance of getting deeper into existing markets rather than pursuing new market expansion, aiming to double or triple the size of current markets.
- The company built a 'mile wide, inch deep' model intentionally and now plans to focus on increasing market share within current regions.
- Leadership indicated that future growth will primarily come from organic deepening rather than de novo branch openings or acquisitions.
- The company is already planning for 2026, with a focus on consolidating and expanding within its current footprint.
- This strategic shift suggests a mature growth phase where depth in existing markets is prioritized over geographic expansion.
- Management highlighted the opportunity to significantly increase market share in their current markets, especially in tertiary MSAs.
- Management highlighted ongoing discussions with private investors for recapitalizing joint ventures, aiming to lower leverage and return capital.
- Plans include selling or converting properties to joint ventures, with 1-2 projects targeted for recapitalization in 2025.
- Recapitalizations are expected to reduce overall leverage, improve credit metrics, and facilitate return to investment-grade status.
- Amerant is transitioning from a national mortgage originator to focusing solely on in-footprint mortgage lending to support retail and private banking customers.
- The company is reducing its mortgage FTE count to under 20 and transferring loans into its core platform, with completion expected by early 4Q.
- Veris Residential has sold or entered contracts for $542 million of non-strategic assets, surpassing the initial $300-$500 million target and raising it to $650 million.
- The company expects the Harborside 8/9 sale to close early next year, generating $0.04 of run rate earnings and further reducing net debt-to-EBITDA to around 9x.
- Proceeds from asset sales are being used to pay down debt, with a goal to delever to below 8x by the end of 2026, significantly strengthening the balance sheet.
- Management emphasized that these strategic asset sales are central to their plan to unlock value and improve financing options, including reducing the cost of capital.
- The company’s focus on monetizing non-core assets is expected to create more optionality and flexibility for future financing and growth strategies.
- Reduced clinical health care exposure to 2.4% of ABR.
- Exited noncore asset classes at solid valuation levels.
- Focused on industrial, retail, and build-to-suit investments to maximize shareholder value.
- No plans to sell remaining clinical or office assets hastily, aiming for disciplined value maximization.
- Invested over $725 million in H1 2025, more than doubling the previous year's first half.
- Raised full-year investment guidance to $1.4-$1.6 billion, a 58% increase over last year.
- Anticipates accelerating investment in Q3 and Q4, with a pipeline supporting over $100 million in development projects before year-end.
- Focus on expanding the company's market position through diversified, non-speculative ground-up development projects with fixed returns.
- Agree Realty achieved its largest quarterly investment volume since COVID, deploying over $450 million in Q3 2025.
- The company increased its full-year 2025 investment guidance to a range of $1.5 to $1.65 billion, up over 65% from last year.
- The investment included 110 high-quality retail properties across multiple sectors, with a weighted average cap rate of 7.2%.
- The pipeline for development and developer funding platforms exceeds $100 million, indicating strong future growth potential.
- The company’s disciplined underwriting standards and strategic partnerships with leading retailers underpin this aggressive growth.